Roth RH, Giarman NJ. Natural occurrence of gamma-hydroxybutyrate in mammalian brain. Biochem Pharmacol 1970; 19: 1087-93.
Snead OC. Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. J Neurochem 2000; 75(5): 1986-96.
Lingenhoehl K, Brom R, Heid J, et al. Gamma-hydroxybutyrate is a weak agonist at recombinant GABA(B) receptors. Neuropharmacology 1999; 38(11): 1667-73.
Carai MAM, Colombo G, Brunetti G, et al. Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol 2001; 428(3): 315-21.
Drasbek KR, Christensen J, Jensen K. Gamma-hydroxybutyrate - a drug of abuse. Acta Neurol Scand 2006; 114(3): 145-56.
Schwartz RH, Milteer R, LeBeau MA. Drug-facilitated sexual assault ("date rape"). South Med.J 2000; 93(6): 558-61.
Elian AA. A novel method for GHB detection in urine and its application in drug-facilitated sexual assaults. Forensic Sci Int 2000; 109(3): 183-7.
Saytzeff A. Naturally occurring metabolite of GABA thought to function as a neurotransmitter or neuromodulator. The hightest cone in humans is found in fetal cerebellum and adult hypothalamus. Ann 1874; 171: 258.
Laborit H, Jouany JM, Gerard J, Fabiani F. Summary of an experimental and clinical study on a metabolic substrate with inhibitory central action: sodium 4-hydroxybutyrate. Presse Med 1960; 68: 1867-9.
Hoes MJ, Vree TB, Guelen PJ. Gamma-hydroxybutyric acid as hypnotic. Clinical and pharmacokinetic evaluation of gamma-hydroxybutyric acid as hypnotic in man. Encephale 1980; 6(1): 93-9.
Addolorato G, Caputo F, Capristo E, Stefanini GF, Gasbarrini G. Gamma-hydroxybutyric acid - Efficacy, potential abuse, and dependence in the treatment of alcohol addiction. Alcohol 2000; 20(3): 217-22.
Takahara J, Yunoki S, Yakushiji W, Yamauchi J, Yamane Y. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol.Metab 1977; 44(5): 1014-7.
Rigamonti AE, Muller EE. Gamma-hydroxybutyric acid and growth hormone secretion studies in rats and dogs. Alcohol 2000; 20(3): 293-304.
Krawczeniuk A. The occurrence of gamma-hydroxybutyric acid (GHB) in a steroid seizure. Microgram 1993; 26(7): 160-6.
Rodgers J, Ashton CH, Gilvarry E, Young AH. Liquid ecstasy: a new kid on the dance floor. Br J Psychiatry 2004; 184: 104-6.
Van Sassenbroeck DK, Calle PA, Rousseau FM, et al. Medical problems related to recreational drug use at nocturnal dance parties. Eur J Emerg Med 2003; 10(4): 302-8.
Drug Abuse Warning Network. Trends in Drug-Related Emergency Department Visits, 1994-2002 At a Glance. https://dawn-info.samhsa.gov, 2003. Last accessed 10-3-2007.
Anderson IB, Kim SY, Dyer JE, et al. Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003. Ann Emerg Med 2006; 47(2): 177-83.
Drug Abuse Warning Network. Drug Abuse Warning Network, 2004: National Estimates of Drug-Related Emergency Department Visits. https://dawninfo.samhsa. gov, 2004. Last accessed 10-3-2007.
Food and Drug Administration. FDA warns about products containing gamma-butyrolactone or GBL and asks companies to issue a recall. FDA Talk Paper. http://www.fda.gov/bbs/topics/answers/ans00937.html, 1999. Last accessed 15-2-2007.
European Medicines Agency (EMEA). Xyrem European Public Assessment Report. http://www.emea.europa.eu/humandocs/Humans/EPAR/xyrem/xyrem.htm, 2007. Last accessed 8-6-2007.
Mamelak M, Scharf MB, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 1986; 9: 285-9.
Scharf MB, Lai AA, Branigan B, Stover R, Berkowitz DB. Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep 1998; 21(5): 507-14.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report 2004: the state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities. 2004:1-113.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report 2005: the state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities. 2005:1-87.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report 2006: the state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities. 2006:1-96.
Epidemiology Unit - Scientific Institute of Public Health. Belgian National Report on Drugs 2006. Sleiman S, Roelands M, (eds). Brussels: Scientific Institute of Public Health. 2006:1-151.
Andersen MB, Netterstrom B. Unconsciousness after ingestion of nail varnish. Ugeskr Laeg 1992; 154(44): 3064.
Thai D, Dyer JE, Jacob P, Haller CA. Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers. Clin Pharmacol. Ther 2007; 81 (2): 178-84.
Lettieri J, Fung HL. Improved pharmacological activity via prodrug modification: comparative pharmacokinetics of sodium gamma-hydroxybutyrate and gamma-butyrolactone. Res Commun Chem Pathol Pharmacol 1978; 22(1): 107-18.
Dupont P, Thornton J. Near-fatal gamma-butyrolactone intoxication - first report in the UK. Hum Exp Toxicol 2001; 20(1): 19-22.
Becker J. A case of gamma-butyrolactone overdose. Clin Toxicol 2000; 38(2): 227.
The Vaults of Erowid. GHB. http://www.erowid.org/chemicals/ghb/, 2007. Last accessed 15-3-2007.
Thai D, Dyer JE, Benowitz NL, Haller CA. Gamma-hydroxybutyrate and ethanol effects and interactions in humans. J Clin Psychopharmacol 2006; 26(5): 524-9.
Brenneisen R, Elsohly MA, Murphy TP, et al. Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. J Anal Toxicol 2004; 28(8): 625-30.
Abanades S, Farre M, Segura M, et al. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann NY Acad. Sci 2006; 1074: 559-76.
Moriya F, Hashimoto Y. Endogenous gamma-hydroxybutyric acid levels in postmortem blood. Leg Med (Tokyo) 2004; 6(1): 47-51.
Elliott SP, Lowe P, Symonds A. The possible influence of microorganisms and putrefaction in the production of GHB in post-mortem biological fluid. Forensic Sci.Int 2004; 139(2-3): 183-90.
Moriya F, Hashimoto Y. Site-dependent production of gamma-hydroxybutyric acid in the early postmortem period. Forensic Sci Int 2005; 148(2-3): 139-42.
Kerrigan S. In vitro production of gamma-hydroxybutyrate in antemortem urine samples. J Anal Toxicol 2002; 26(8): 571-4.
Elliott SP. Further evidence for the presence of GHB in postmortem biological fluid: implications for the interpretation of f indings. J Anal Toxicol 2004; 28(1): 20-6.
LeBeau MA, Miller ML, Levine B. Effect of storage temperature on endogenous GHB levels in urine. Forensic Sci Int 2001; 119(2): 161-7.
Balikova M. Gamma-hydroxybutyrate (GHB) misuse or abuse and interpretation of toxicological findings. Soud Lek 2005; 50(1): 7-9.
Chin RL, Sporer KA, Cullison B, Dyer JE, Wu TD. Clinical course of gamma-hydroxybutyrate overdose. Ann Emerg Med 1998; 31 (6): 716-22.
Dyer JE, Roth B, Hyma BA. Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 2001; 37(2): 147-53.
Couper FJ, Logan BK. Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography-mass spectrometry. J Anal Toxicol 2000; 24(1): 1-7.
Elian AA. GC-MS determination of gamma-hydroxybutyric acid (GHB) in blood. Forensic Sci.In. 2001; 122(1): 43-7.
Villain M, Cirimele V, Ludes B, Kintz P. Ultra-rapid procedure to test for gamma-hydroxybutyric acid in blood and urine by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 792(1): 83-7.
Duer WC, Byers KL, Martin JV. Application of a convenient extraction procedure to analyze gamma-hydroxybutyric acid in fatalities involving gamma-hydroxybutyric acid, gamma-butyrolactone, and 1,4-butanediol. J Anal Toxicol 2001; 25(7): 576-82.
Shima N, Miki A, Kamata T, Katagi M, Tsuchihashi H. Urinary endogenous concentrations of GHB and its isomers in healthy humans and diabetics. Forensic Sci Int 2005; 149(2-3): 171-9.
Abanades S, Farre M, Segura M, et al. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics. Ann NY Acad. Sci 2006; 1074: 559-76.
Kintz P, Villain M, Pelissier AL, Cirimele V, Leonetti G. Unusually high concentrations in a fatal GHB case. J Anal Toxicol 2005; 29(6): 582-5.
Louagie HK, Verstraete AG, De Soete CJ, Baetens DG, Calle PA. A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol. J Toxicol Clin Toxicol 1997; 35(6): 591-4.
Segers S, Van Sassenbroeck DK, Verstraete AG, Martens P. Gammahydroxyboterzuur (GHB): van een anesthesieproduct naar illegale drug. Tijdschr Geneeskd 2002; 58(1): 49-54.
Mazarr-Proo S, Kerrigan S. Distribution of GHB in tissues and fluids following a fatal overdose. J Anal Toxicol 2005; 29(5): 398-400.
Stephens BG, Baselt RC. Driving under the influence of GHB? J Anal Toxicol 1994; 18(6): 357-8.
Caldicott DG, Chow FY, Burns BJ, Felgate PD, Byard RW. Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia. Med. J Aust. 2004; 181(6): 310-3.
Ferrara SD, Tedeschi L, Frison G, Rossi A. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication. J Forensic Sci 1995; 40(3): 501-4.
Dyer JE, Isaacs SM, Keller KH. Gamma-hydroxybutyrate (GHB)-induced coma with serum and urine drugs levels. Vet Hum Toxicol 1994; 36: 339.
Sporer KA, Chin RL, Dyer JE, Lamb R. Gamma-hydroxybutyrate serum levels and clinical syndrome after severe overdose. Ann Emerg. Med 2003; 42(1): 3-8.
Elliott SP. Nonfatal instances of intoxication with gamma-hydroxybutyrate in the United Kingdom. Ther Drug .Monit 2004; 26(4): 432-40.
Couper FJ, Thatcher JE, Logan BK. Suspected GHB overdoses in the emergency department. J Anal Toxicol 2004; 28(6): 481-4.
Deveaux M, Renet S, Renet V, et al. Use of gamma-hydroxybutyric acid (GHB) at rave parties and in date rape in France: myth of reality? Acta Clin.Belg Suppl 2002; 1(1): 37-40.
WHO's Expert Committee on Drug Dependence (ECDD). Prereview of gamma-hydroxybutyric acid (GHB). 2006;WHO ECDD 34th Meeting: 1-31.
McCusker RR, Paget-Wilkes H, Chronister CW, Goldberger BA. Analysis of gamma-hydroxybutyrate (GHB) in urine by gas chromatography-mass spectrometry. J Anal Toxicol 1999; 23(5): 301-5.
